Scalp Cooling System Market Growth is estimated to Accelerated by Growing Cancer Cases

 


Scalp cooling systems help prevent hair loss associated with chemotherapy by reducing the amount of chemotherapy drug absorbed by hair follicles. They utilize specialized cooling caps to lower the scalp temperature and constrict hair follicles and blood vessels, thereby protecting hair follicles from the toxic effects of chemotherapy.

The global Scalp Cooling System Market is estimated to be valued at US$ 130 million in 2023 and is expected to exhibit a CAGR of 15.82% over the forecast period for 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The demand for scalp cooling systems has been growing due to the rising prevalence of cancer and increasing number of chemotherapy procedures performed worldwide annually. It is estimated that over 18 million new cancer cases were reported globally in 2023. Scalp cooling allows cancer patients to maintain their hair and normal appearance during chemotherapy treatment, which positively impacts their psychological well-being. This has been a major factor boosting the adoption of scalp cooling systems. The growing awareness about scalp cooling and its benefits is further expected to fuel the market growth over the forecast period.


Segment Analysis
The global scalp cooling system market is dominated by scalp cooling chemotherapy cap sub segment. This sub segment holds around 80% of the total market share as scalp cooling chemotherapy cap is the most effective and widely used cooling method during chemotherapy. It helps in preventing hair fall by lowering the scalp temperature during chemotherapy sessions.

Key Takeaways
The global scalp cooling system market is expected to witness high growth over the forecast period 2023-2030. The global Scalp Cooling System Market is estimated to be valued at US$ 130 million in 2023 and is expected to exhibit a CAGR of 15.82% over the forecast period for 2023-2030.


Regional analysis
North America holds the largest share in the global scalp cooling system market mainly due to presence of advanced healthcare infrastructure, higher adoption of advanced scalp cooling technologies, and favorable reimbursement policies in the region. The United States alone captures around 70% of the North American scalp cooling system market.

Key players operating in the scalp cooling system market are Dignitana Inc., Penguin Cold Caps, and Paxman. Dignitana Inc. holds the major share of around 35% due to its patented technological scalp cooling system used for protection during chemotherapy.

Comments

Post a Comment

Popular posts from this blog

Fibrinolytic Therapy is Anticipated to Witness Moderate Growth Owing to Rising Prevalence of Cardiovascular Diseases

Image
The global fibrinolytic therapy market is estimated to be valued at US$ 34.96 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period of 2023 to 2030. Fibrinolytic therapy, also called thrombolysis, involves the use of clot-busting drugs to dissolve blood clots and restore blood flow. Rising prevalence of cardiovascular diseases such as heart attacks and strokes has increased the demand for fibrinolytic drugs worldwide. Fibrinolytic therapy improves patient outcomes and recovery rates by dissolving the clots blocking arteries and restoring blood flow to tissues and organs. Key players operating in the fibrinolytic therapy market are Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Mitsub...
Read more

Intraocular Lens Market to Witness High Growth Due to Rising Prevalence of Cataract Across Globe

Image
Intraocular lens (IOL) is an artificial lens which is implanted inside eyes during cataract surgery to replace clouded eye lenses. IOL helps enhance vision and provides independence from glasses or contact lenses by helping patients restore clarity of vision. IOLs act as replacement for eye's natural crystalline lens after cataract removal. The global intraocular lens market is mainly driven by rising geriatric population suffering from age-related cataracts across the globe. Cataract is common age-related eye disease, affecting vision and quality of life of elderly people. As per the World Health Organization (WHO), cataracts are the leading cause of blindness globally affecting over 38 million population worldwide. Growing cases of cataract and demand for its minimally invasive surgeries are propelling market growth. The Global intraocular lens market is estimated to be valued at US$ 5,076.1 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to ...
Read more

Exploring the Frontiers of Healthcare: In Vitro Diagnostics (IVD)

Image
  In today's era of cutting-edge medical technology, the field of diagnostics plays a pivotal role in healthcare. Among the various diagnostic methods available, in vitro diagnostics (IVD) stands out as a cornerstone of modern medicine. IVD encompasses a wide range of tests performed on bodily fluids or tissue samples outside the body, providing valuable insights into a patient's health status and aiding in the diagnosis, treatment, and monitoring of diseases. From routine screenings to complex molecular analyses, IVD has revolutionized medical practice, paving the way for personalized and precise healthcare interventions. Understanding In Vitro Diagnostics : In vitro, Latin for "in glass," denotes tests conducted in a controlled laboratory setting, outside the living organism. In the context of diagnostics, this involves analyzing biological specimens such as blood, urine, saliva, and tissue samples collected from patients. IVD techniques utilize various analytical m...
Read more